This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders Europe
17 - 19 March 2026
Austria CenterAustria Center, Vienna
Book Now
Menu
Book
Key Sessions
Marie Wikstrom-Lindholm
Keynote Panel: The Potential of RNA Therapeutics – Rare vs Broad Spectrum Conditions
Silence Therapeutics
keyboard_arrow_right

Main Conference – Day 1 - CET (Central European Time, GMT+01:00)

keyboard_arrow_leftSearch & Filter
close
Main Conference – Day 1 - CET (Central European Time, GMT+01:00)
close
Showing 1 of 1 Streams
16:45 - 17:15
Presentation: Exploring Cell-Free RNA: Pioneering Advances in RNA Therapeutics and Biomarker Development
  • Cell-free RNAs (cfRNAs), stabilized by extracellular vesicles (EVs), lipoproteins, and RNA-binding proteins (RBPs), are emerging as key players in RNA therapeutics and biomarker research, with a focus on their role in cell-to-cell communication.
  • Recent findings emphasize the importance of RBPs in cfRNA biology, highlighting their potential to enhance stability, specificity, and targeted uptake for next-generation RNA therapeutics. cfRNAs also show promise as non-invasive biomarkers for real-time monitoring of therapeutic efficacy and optimizing personalized treatments.
  • Integrating cfRNA discoveries into RNA therapeutic pipelines offers the potential to advance individualized treatment strategies, improve patient outcomes, and set new standards in RNA-based medicine.
  • Bogdan Rivoal - CEO, NeXendia
Pre-Conference Day
NextMain Conference – Day 2
Filter
Streams
Formats
Choose Day